Added to YB: 2021-07-05
Pitch date: 2021-07-05
BIIB [bullish]
Biogen Inc.
-49.44%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Market Cap
$24.8B
Pitch Price
$347.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.78
P/E
15.38
EV/Sales
2.72
Sector
Biotechnology
Category
N/A
Show full summary:
BIOGEN INC BIIB
A summary for this pitch has not been created yet.
Read full article (0 min)